WEED Fundamental Analysis - CANOPY GROWTH CORP

Fundamental Rating

Taking everything into account, WEED scores 3 out of 10 in our fundamental rating. WEED was compared to 32 industry peers in the Pharmaceuticals industry. While WEED seems to be doing ok healthwise, there are quite some concerns on its profitability. WEED has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

WEED had negative earnings in the past year.

WEED had a negative operating cash flow in the past year.

WEED had negative earnings in each of the past 5 years.

WEED had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

WEED's Return On Assets of -36.07% is on the low side compared to the rest of the industry. WEED is outperformed by 71.88% of its industry peers.

The Return On Equity of WEED (-52.42%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-36.07%
ROE	-52.42%
ROIC	N/A

ROA(3y)-83.37%

ROA(5y)-56.25%

ROE(3y)-219.63%

ROE(5y)-143.17%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 27.49%, WEED is in line with its industry, outperforming 43.75% of the companies in the same industry.

WEED does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	27.49%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for WEED has been increased compared to 1 year ago.

The number of shares outstanding for WEED has been reduced compared to 5 years ago.

The debt/assets ratio for WEED has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -9.37, we must say that WEED is in the distress zone and has some risk of bankruptcy.

WEED has a Altman-Z score of -9.37. This is amonst the worse of the industry: WEED underperforms 81.25% of its industry peers.

A Debt/Equity ratio of 0.33 indicates that WEED is not too dependend on debt financing.

The Debt to Equity ratio of WEED (0.33) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Altman-Z	-9.37

ROIC/WACCN/A

WACC10.59%

2.3 Liquidity

A Current Ratio of 5.50 indicates that WEED has no problem at all paying its short term obligations.

With an excellent Current ratio value of 5.50, WEED belongs to the best of the industry, outperforming 96.88% of the companies in the same industry.

A Quick Ratio of 4.23 indicates that WEED has no problem at all paying its short term obligations.

WEED has a better Quick ratio (4.23) than 96.88% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	5.5
Quick Ratio	4.23

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

WEED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.25%, which is quite impressive.

WEED shows a decrease in Revenue. In the last year, the revenue decreased by -0.67%.

The Revenue has been decreasing by -7.57% on average over the past years.

EPS 1Y (TTM)58.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.32%

Revenue 1Y (TTM)-0.67%

Revenue growth 3Y-19.22%

Revenue growth 5Y-7.57%

Sales Q2Q%5.86%

3.2 Future

Based on estimates for the next years, WEED will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.29% on average per year.

The Revenue is expected to grow by 5.39% on average over the next years.

EPS Next Y94.86%

EPS Next 2Y40.65%

EPS Next 3Y25.5%

EPS Next 5Y15.29%

Revenue Next Year2.14%

Revenue Next 2Y4.71%

Revenue Next 3Y30.84%

Revenue Next 5Y5.39%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

WEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

WEED's earnings are expected to grow with 25.50% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y40.65%

EPS Next 3Y25.5%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

WEED does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CANOPY GROWTH CORP

TSX:WEED (1/2/2026, 7:00:00 PM)

1.64

+0.08 (+5.13%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)11-07 2025-11-07/bmo

Earnings (Next)02-05 2026-02-05/bmo

Inst Owners11.18%

Inst Owner ChangeN/A

Ins Owners0.18%

Ins Owner ChangeN/A

Market Cap604.27M

Revenue(TTM)278.61M

Net Income(TTM)-385.85M

Analysts47.69

Price Target3.88 (136.59%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)51.01%

Min EPS beat(2)8.22%

Max EPS beat(2)93.8%

EPS beat(4)2

Avg EPS beat(4)-51.44%

Min EPS beat(4)-206.63%

Max EPS beat(4)93.8%

EPS beat(8)2

Avg EPS beat(8)-152.68%

EPS beat(12)3

Avg EPS beat(12)-166.46%

EPS beat(16)4

Avg EPS beat(16)-163.73%

Revenue beat(2)1

Avg Revenue beat(2)0.9%

Min Revenue beat(2)-7.76%

Max Revenue beat(2)9.57%

Revenue beat(4)3

Avg Revenue beat(4)3.88%

Min Revenue beat(4)-7.76%

Max Revenue beat(4)9.57%

Revenue beat(8)5

Avg Revenue beat(8)2.85%

Revenue beat(12)6

Avg Revenue beat(12)1.1%

Revenue beat(16)8

Avg Revenue beat(16)-0.85%

PT rev (1m)2.7%

PT rev (3m)2.7%

EPS NQ rev (1m)0%

EPS NQ rev (3m)70.39%

EPS NY rev (1m)0%

EPS NY rev (3m)58.18%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-8.94%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-5.7%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.17
P/FCF	N/A
P/OCF	N/A
P/B	0.82
P/tB	1
EV/EBITDA	N/A

EPS(TTM)-2.81

EYN/A

EPS(NY)-0.12

Fwd EYN/A

FCF(TTM)-0.26

FCFYN/A

OCF(TTM)-0.24

OCFYN/A

SpS0.76

BVpS2

TBVpS1.65

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-36.07%
ROE	-52.42%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	27.49%
FCFM	N/A

ROA(3y)-83.37%

ROA(5y)-56.25%

ROE(3y)-219.63%

ROE(5y)-143.17%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.26

Health

		Industry Rank	Sector Rank
Debt/Equity	0.33
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	18.94%
Cap/Sales	2.77%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	5.5
Quick Ratio	4.23
Altman-Z	-9.37

F-Score5

WACC10.59%

ROIC/WACCN/A

Cap/Depr(3y)15.39%

Cap/Depr(5y)45.04%

Cap/Sales(3y)2.72%

Cap/Sales(5y)9.89%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)58.25%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.32%

EPS Next Y94.86%

EPS Next 2Y40.65%

EPS Next 3Y25.5%

EPS Next 5Y15.29%

Revenue 1Y (TTM)-0.67%

Revenue growth 3Y-19.22%

Revenue growth 5Y-7.57%

Sales Q2Q%5.86%

Revenue Next Year2.14%

Revenue Next 2Y4.71%

Revenue Next 3Y30.84%

Revenue Next 5Y5.39%

EBIT growth 1Y51.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year89.39%

EBIT Next 3Y31%

EBIT Next 5Y19.3%

FCF growth 1Y81.5%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y82.69%

OCF growth 3YN/A

OCF growth 5YN/A

CANOPY GROWTH CORP / WEED.CA FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to WEED.CA.

Can you provide the valuation status for CANOPY GROWTH CORP?

ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (WEED.CA). This can be considered as Overvalued.

How profitable is CANOPY GROWTH CORP (WEED.CA) stock?

CANOPY GROWTH CORP (WEED.CA) has a profitability rating of 0 / 10.

Can you provide the expected EPS growth for WEED stock?

The Earnings per Share (EPS) of CANOPY GROWTH CORP (WEED.CA) is expected to grow by 94.86% in the next year.

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CANOPY GROWTH CORP / WEED.CA FAQ

Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?

Can you provide the valuation status for CANOPY GROWTH CORP?

How profitable is CANOPY GROWTH CORP (WEED.CA) stock?

Can you provide the expected EPS growth for WEED stock?